Effect of interleukin 1b inhibition with canakinumab on inflammation and viral persistence in people with human immunodeficiency virus
30 August 2024 (08:00 - 17:30)
Organised by: 
About the speaker
University of California, Los Angeles, Los Angeles (United States of America)
8 More presentations in this session
Professor N. Vuilleumier (Geneva, CH)
Doctor A. Preveden (Sremska Kamenica, RS)
Ms N. Laptseva (Zurich, CH)
Access the full session
The Event
ESC Congress 2024
30 August - 2 September 2024
